Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_assertion type Assertion NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_head.
- NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_assertion description "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_provenance.
- NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_assertion evidence source_evidence_literature NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_provenance.
- NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_assertion SIO_000772 20713525 NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_provenance.
- NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_assertion wasDerivedFrom befree-20140225 NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_provenance.
- NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_assertion wasGeneratedBy ECO_0000203 NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_provenance.